Athira Pharma (ATHA) Reports Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton – StreetInsider.com

Athira Pharma (ATHA) Reports Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton – StreetInsider.com
Source: Google NewsPublished on 2022-06-22